Proceedings Of The Fifth International Congress Of Therapeutic Drug Monitoring And Clinical ToxicologyClinical Assessment of DNA Analysis for ToxicologyWeedn, Victor WalterAuthor Information Birmingham Regional Crime Laboratory, Alabama Department of Forensic Sciences, Birmingham, Alabama, USA Received March 18, 1998; accepted April 11, 1998. Presented at the 5th International Congress on Therapeutic Drug Monitoring and Clinical Chemistry, Vancouver, British Columbia, Canada, November 13, 1997. Address correspondence and reprint requests to Victor Walter Weedn, Birmingham Regional Crime Laboratory, Alabama Department of Forensic Sciences, 1001 13th Street South, PO Box 55725, Birmingham, AL 35255-5725, USA. Therapeutic Drug Monitoring: October 1998 - Volume 20 - Issue 5 - p 532-538 Buy Abstract The impact of discoveries in biotechnology-particularly those dealing with DNA-will be among the most significant factors changing the world in the next decade. Toxicologists will not escape this change; they, too, will be significantly impacted by the new genetics. © 1998 Lippincott Williams & Wilkins, Inc.